Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance

被引:0
作者
Probin Kr Roy
Johirul Islam
Hauzel Lalhlenmawia
机构
[1] Regional Institute of Paramedical and Nursing Sciences (RIPANS),Department of Pharmacy
[2] Coromandel International Limited,undefined
来源
The Egyptian Heart Journal | / 75卷
关键词
Adipokines; Adipose tissue dysfunction; Anti-inflammatory adipokines; Atherogenic dyslipidemia; Insulin resistance; Metabolic disorder;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 977 条
[1]  
Green M(2020)Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome Int J Mol Sci 21 2890-259
[2]  
Arora K(2014)Adipokines: a link between obesity and cardiovascular disease J Cardiol 63 250-206
[3]  
Prakash S(2019)Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases Biochem Pharmacol 165 196-S3
[4]  
Nakamura K(2006)Childhood obesity: a pandemic of the twenty-first century Int J Obes 30 S1-327
[5]  
Fuster JJ(2019)Immunity and inflammation in atherosclerosis Circ Res 124 315-149
[6]  
Walsh K(2021)Adiponectin, leptin and cardiovascular disorders Circ Res 128 136-880
[7]  
Francisco V(2020)Metabolic syndrome: past, present and future Nutrients 12 3501-7539
[8]  
Ruiz-Fernández C(2006)Mechanisms linking obesity with cardiovascular disease Nature 444 875-559
[9]  
Pino J(2019)Adipose tissue dysfunction as determinant of obesity-associated metabolic complications Int J Mol Sci 20 2358-1807
[10]  
Mera A(2020)Adipokines and adipose tissue-related metabolites, nuts and cardiovascular disease Metabolites 10 32-32